Molecular targets for diagnostics and therapeutics of severe acute respiratory syndrome (SARS-CoV).
Identifieur interne : 001A85 ( PubMed/Checkpoint ); précédent : 001A84; suivant : 001A86Molecular targets for diagnostics and therapeutics of severe acute respiratory syndrome (SARS-CoV).
Auteurs : Mavanur R. Suresh [Canada] ; Pravin K. Bhatnagar ; Dipankar DasSource :
- Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques [ 1482-1826 ] ; 2008.
Descripteurs français
- KwdFr :
- Administration par voie nasale, Animaux, Anticorps antiviraux (immunologie), Antigènes viraux (administration et posologie), Antigènes viraux (analyse), Antigènes viraux (immunologie), Canada, Cellules Vero, Protéines de l'enveloppe virale (immunologie), Protéines nucléocapside (immunologie), Protéines virales (administration et posologie), Protéines virales (immunologie), RT-PCR, Syndrome respiratoire aigu sévère (), Syndrome respiratoire aigu sévère (diagnostic), Syndrome respiratoire aigu sévère (génétique), Syndrome respiratoire aigu sévère (immunologie), Syndrome respiratoire aigu sévère (traitement médicamenteux), Test ELISA, Tests de neutralisation, Vaccins antiviraux (immunologie), Vaccins antiviraux (usage thérapeutique), Virus du SRAS (génétique), Virus du SRAS (immunologie), Virus du SRAS (isolement et purification), Épitopes (génétique), Épitopes (immunologie).
- MESH :
- administration et posologie : Antigènes viraux, Protéines virales.
- analyse : Antigènes viraux.
- diagnostic : Syndrome respiratoire aigu sévère.
- génétique : Syndrome respiratoire aigu sévère, Virus du SRAS, Épitopes.
- immunologie : Anticorps antiviraux, Antigènes viraux, Protéines de l'enveloppe virale, Protéines nucléocapside, Protéines virales, Syndrome respiratoire aigu sévère, Vaccins antiviraux, Virus du SRAS, Épitopes.
- isolement et purification : Virus du SRAS.
- traitement médicamenteux : Syndrome respiratoire aigu sévère.
- usage thérapeutique : Vaccins antiviraux.
- Administration par voie nasale, Animaux, Canada, Cellules Vero, RT-PCR, Syndrome respiratoire aigu sévère, Test ELISA, Tests de neutralisation.
- Wicri :
- geographic : Canada.
English descriptors
- KwdEn :
- Administration, Intranasal, Animals, Antibodies, Viral (immunology), Antigens, Viral (administration & dosage), Antigens, Viral (analysis), Antigens, Viral (immunology), Canada, Chlorocebus aethiops, Enzyme-Linked Immunosorbent Assay, Epitopes (genetics), Epitopes (immunology), Neutralization Tests, Nucleocapsid Proteins (immunology), Reverse Transcriptase Polymerase Chain Reaction, SARS Virus (genetics), SARS Virus (immunology), SARS Virus (isolation & purification), Severe Acute Respiratory Syndrome (diagnosis), Severe Acute Respiratory Syndrome (drug therapy), Severe Acute Respiratory Syndrome (genetics), Severe Acute Respiratory Syndrome (immunology), Severe Acute Respiratory Syndrome (prevention & control), Vero Cells, Viral Envelope Proteins (immunology), Viral Proteins (administration & dosage), Viral Proteins (immunology), Viral Vaccines (immunology), Viral Vaccines (therapeutic use).
- MESH :
- chemical , administration & dosage : Antigens, Viral, Viral Proteins.
- chemical , analysis : Antigens, Viral.
- chemical , genetics : Epitopes.
- chemical , immunology : Antibodies, Viral, Antigens, Viral, Epitopes, Nucleocapsid Proteins, Viral Envelope Proteins, Viral Proteins, Viral Vaccines.
- chemical , therapeutic use : Viral Vaccines.
- geographic : Canada.
- diagnosis : Severe Acute Respiratory Syndrome.
- drug therapy : Severe Acute Respiratory Syndrome.
- genetics : SARS Virus, Severe Acute Respiratory Syndrome.
- immunology : SARS Virus, Severe Acute Respiratory Syndrome.
- isolation & purification : SARS Virus.
- prevention & control : Severe Acute Respiratory Syndrome.
- Administration, Intranasal, Animals, Chlorocebus aethiops, Enzyme-Linked Immunosorbent Assay, Neutralization Tests, Reverse Transcriptase Polymerase Chain Reaction, Vero Cells.
Abstract
The large number of deaths in a short period of time due to the spread of severe acute respiratory syndrome (SARS) infection led to the unparalleled collaborative efforts world wide to determine and characterize the new coronavirus (SARS-CoV). The full genome sequence was determined within weeks of the first outbreak by the Canadian group with international collaboration. As per the World Health Organization (WHO), the continual lack of a rapid laboratory test to aid the early diagnosis of suspected cases of SARS makes this area a priority for future research. To prevent deaths in the future, early diagnosis and therapy of this infectious disease is of paramount importance.
DOI: 10.18433/j3j019
PubMed: 19203466
Affiliations:
Links toward previous steps (curation, corpus...)
Links to Exploration step
pubmed:19203466Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Molecular targets for diagnostics and therapeutics of severe acute respiratory syndrome (SARS-CoV).</title>
<author><name sortKey="Suresh, Mavanur R" sort="Suresh, Mavanur R" uniqKey="Suresh M" first="Mavanur R" last="Suresh">Mavanur R. Suresh</name>
<affiliation wicri:level="1"><nlm:affiliation>Faculty of Pharmacy and Pharmaceutical Sciences, University of Alberta, Edmonton, Alberta, Canada. msuresh@pharmacy.ualberta.ca</nlm:affiliation>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>Faculty of Pharmacy and Pharmaceutical Sciences, University of Alberta, Edmonton, Alberta</wicri:regionArea>
<wicri:noRegion>Alberta</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Bhatnagar, Pravin K" sort="Bhatnagar, Pravin K" uniqKey="Bhatnagar P" first="Pravin K" last="Bhatnagar">Pravin K. Bhatnagar</name>
</author>
<author><name sortKey="Das, Dipankar" sort="Das, Dipankar" uniqKey="Das D" first="Dipankar" last="Das">Dipankar Das</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2008">2008</date>
<idno type="RBID">pubmed:19203466</idno>
<idno type="pmid">19203466</idno>
<idno type="doi">10.18433/j3j019</idno>
<idno type="wicri:Area/PubMed/Corpus">001965</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">001965</idno>
<idno type="wicri:Area/PubMed/Curation">001965</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">001965</idno>
<idno type="wicri:Area/PubMed/Checkpoint">001A85</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">001A85</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Molecular targets for diagnostics and therapeutics of severe acute respiratory syndrome (SARS-CoV).</title>
<author><name sortKey="Suresh, Mavanur R" sort="Suresh, Mavanur R" uniqKey="Suresh M" first="Mavanur R" last="Suresh">Mavanur R. Suresh</name>
<affiliation wicri:level="1"><nlm:affiliation>Faculty of Pharmacy and Pharmaceutical Sciences, University of Alberta, Edmonton, Alberta, Canada. msuresh@pharmacy.ualberta.ca</nlm:affiliation>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>Faculty of Pharmacy and Pharmaceutical Sciences, University of Alberta, Edmonton, Alberta</wicri:regionArea>
<wicri:noRegion>Alberta</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Bhatnagar, Pravin K" sort="Bhatnagar, Pravin K" uniqKey="Bhatnagar P" first="Pravin K" last="Bhatnagar">Pravin K. Bhatnagar</name>
</author>
<author><name sortKey="Das, Dipankar" sort="Das, Dipankar" uniqKey="Das D" first="Dipankar" last="Das">Dipankar Das</name>
</author>
</analytic>
<series><title level="j">Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques</title>
<idno type="eISSN">1482-1826</idno>
<imprint><date when="2008" type="published">2008</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Administration, Intranasal</term>
<term>Animals</term>
<term>Antibodies, Viral (immunology)</term>
<term>Antigens, Viral (administration & dosage)</term>
<term>Antigens, Viral (analysis)</term>
<term>Antigens, Viral (immunology)</term>
<term>Canada</term>
<term>Chlorocebus aethiops</term>
<term>Enzyme-Linked Immunosorbent Assay</term>
<term>Epitopes (genetics)</term>
<term>Epitopes (immunology)</term>
<term>Neutralization Tests</term>
<term>Nucleocapsid Proteins (immunology)</term>
<term>Reverse Transcriptase Polymerase Chain Reaction</term>
<term>SARS Virus (genetics)</term>
<term>SARS Virus (immunology)</term>
<term>SARS Virus (isolation & purification)</term>
<term>Severe Acute Respiratory Syndrome (diagnosis)</term>
<term>Severe Acute Respiratory Syndrome (drug therapy)</term>
<term>Severe Acute Respiratory Syndrome (genetics)</term>
<term>Severe Acute Respiratory Syndrome (immunology)</term>
<term>Severe Acute Respiratory Syndrome (prevention & control)</term>
<term>Vero Cells</term>
<term>Viral Envelope Proteins (immunology)</term>
<term>Viral Proteins (administration & dosage)</term>
<term>Viral Proteins (immunology)</term>
<term>Viral Vaccines (immunology)</term>
<term>Viral Vaccines (therapeutic use)</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr"><term>Administration par voie nasale</term>
<term>Animaux</term>
<term>Anticorps antiviraux (immunologie)</term>
<term>Antigènes viraux (administration et posologie)</term>
<term>Antigènes viraux (analyse)</term>
<term>Antigènes viraux (immunologie)</term>
<term>Canada</term>
<term>Cellules Vero</term>
<term>Protéines de l'enveloppe virale (immunologie)</term>
<term>Protéines nucléocapside (immunologie)</term>
<term>Protéines virales (administration et posologie)</term>
<term>Protéines virales (immunologie)</term>
<term>RT-PCR</term>
<term>Syndrome respiratoire aigu sévère ()</term>
<term>Syndrome respiratoire aigu sévère (diagnostic)</term>
<term>Syndrome respiratoire aigu sévère (génétique)</term>
<term>Syndrome respiratoire aigu sévère (immunologie)</term>
<term>Syndrome respiratoire aigu sévère (traitement médicamenteux)</term>
<term>Test ELISA</term>
<term>Tests de neutralisation</term>
<term>Vaccins antiviraux (immunologie)</term>
<term>Vaccins antiviraux (usage thérapeutique)</term>
<term>Virus du SRAS (génétique)</term>
<term>Virus du SRAS (immunologie)</term>
<term>Virus du SRAS (isolement et purification)</term>
<term>Épitopes (génétique)</term>
<term>Épitopes (immunologie)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="administration & dosage" xml:lang="en"><term>Antigens, Viral</term>
<term>Viral Proteins</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="analysis" xml:lang="en"><term>Antigens, Viral</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="genetics" xml:lang="en"><term>Epitopes</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="immunology" xml:lang="en"><term>Antibodies, Viral</term>
<term>Antigens, Viral</term>
<term>Epitopes</term>
<term>Nucleocapsid Proteins</term>
<term>Viral Envelope Proteins</term>
<term>Viral Proteins</term>
<term>Viral Vaccines</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Viral Vaccines</term>
</keywords>
<keywords scheme="MESH" type="geographic" xml:lang="en"><term>Canada</term>
</keywords>
<keywords scheme="MESH" qualifier="administration et posologie" xml:lang="fr"><term>Antigènes viraux</term>
<term>Protéines virales</term>
</keywords>
<keywords scheme="MESH" qualifier="analyse" xml:lang="fr"><term>Antigènes viraux</term>
</keywords>
<keywords scheme="MESH" qualifier="diagnosis" xml:lang="en"><term>Severe Acute Respiratory Syndrome</term>
</keywords>
<keywords scheme="MESH" qualifier="diagnostic" xml:lang="fr"><term>Syndrome respiratoire aigu sévère</term>
</keywords>
<keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Severe Acute Respiratory Syndrome</term>
</keywords>
<keywords scheme="MESH" qualifier="genetics" xml:lang="en"><term>SARS Virus</term>
<term>Severe Acute Respiratory Syndrome</term>
</keywords>
<keywords scheme="MESH" qualifier="génétique" xml:lang="fr"><term>Syndrome respiratoire aigu sévère</term>
<term>Virus du SRAS</term>
<term>Épitopes</term>
</keywords>
<keywords scheme="MESH" qualifier="immunologie" xml:lang="fr"><term>Anticorps antiviraux</term>
<term>Antigènes viraux</term>
<term>Protéines de l'enveloppe virale</term>
<term>Protéines nucléocapside</term>
<term>Protéines virales</term>
<term>Syndrome respiratoire aigu sévère</term>
<term>Vaccins antiviraux</term>
<term>Virus du SRAS</term>
<term>Épitopes</term>
</keywords>
<keywords scheme="MESH" qualifier="immunology" xml:lang="en"><term>SARS Virus</term>
<term>Severe Acute Respiratory Syndrome</term>
</keywords>
<keywords scheme="MESH" qualifier="isolation & purification" xml:lang="en"><term>SARS Virus</term>
</keywords>
<keywords scheme="MESH" qualifier="isolement et purification" xml:lang="fr"><term>Virus du SRAS</term>
</keywords>
<keywords scheme="MESH" qualifier="prevention & control" xml:lang="en"><term>Severe Acute Respiratory Syndrome</term>
</keywords>
<keywords scheme="MESH" qualifier="traitement médicamenteux" xml:lang="fr"><term>Syndrome respiratoire aigu sévère</term>
</keywords>
<keywords scheme="MESH" qualifier="usage thérapeutique" xml:lang="fr"><term>Vaccins antiviraux</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Administration, Intranasal</term>
<term>Animals</term>
<term>Chlorocebus aethiops</term>
<term>Enzyme-Linked Immunosorbent Assay</term>
<term>Neutralization Tests</term>
<term>Reverse Transcriptase Polymerase Chain Reaction</term>
<term>Vero Cells</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr"><term>Administration par voie nasale</term>
<term>Animaux</term>
<term>Canada</term>
<term>Cellules Vero</term>
<term>RT-PCR</term>
<term>Syndrome respiratoire aigu sévère</term>
<term>Test ELISA</term>
<term>Tests de neutralisation</term>
</keywords>
<keywords scheme="Wicri" type="geographic" xml:lang="fr"><term>Canada</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">The large number of deaths in a short period of time due to the spread of severe acute respiratory syndrome (SARS) infection led to the unparalleled collaborative efforts world wide to determine and characterize the new coronavirus (SARS-CoV). The full genome sequence was determined within weeks of the first outbreak by the Canadian group with international collaboration. As per the World Health Organization (WHO), the continual lack of a rapid laboratory test to aid the early diagnosis of suspected cases of SARS makes this area a priority for future research. To prevent deaths in the future, early diagnosis and therapy of this infectious disease is of paramount importance.</div>
</front>
</TEI>
<pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">19203466</PMID>
<DateCompleted><Year>2009</Year>
<Month>04</Month>
<Day>28</Day>
</DateCompleted>
<DateRevised><Year>2019</Year>
<Month>12</Month>
<Day>10</Day>
</DateRevised>
<Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1482-1826</ISSN>
<JournalIssue CitedMedium="Internet"><Volume>11</Volume>
<Issue>2</Issue>
<PubDate><Year>2008</Year>
<Month>Apr</Month>
<Day>19</Day>
</PubDate>
</JournalIssue>
<Title>Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques</Title>
<ISOAbbreviation>J Pharm Pharm Sci</ISOAbbreviation>
</Journal>
<ArticleTitle>Molecular targets for diagnostics and therapeutics of severe acute respiratory syndrome (SARS-CoV).</ArticleTitle>
<Pagination><MedlinePgn>1s-13s</MedlinePgn>
</Pagination>
<Abstract><AbstractText Label="PURPOSE" NlmCategory="OBJECTIVE">The large number of deaths in a short period of time due to the spread of severe acute respiratory syndrome (SARS) infection led to the unparalleled collaborative efforts world wide to determine and characterize the new coronavirus (SARS-CoV). The full genome sequence was determined within weeks of the first outbreak by the Canadian group with international collaboration. As per the World Health Organization (WHO), the continual lack of a rapid laboratory test to aid the early diagnosis of suspected cases of SARS makes this area a priority for future research. To prevent deaths in the future, early diagnosis and therapy of this infectious disease is of paramount importance.</AbstractText>
<AbstractText Label="METHODS" NlmCategory="METHODS">This review describes the specific molecular targets for diagnostics and therapeutics of viral infection.</AbstractText>
<AbstractText Label="RESULTS" NlmCategory="RESULTS">The three major diagnostic methods available for SARS includes viral RNA detection by reverse transcription polymerase chain reaction (RT-PCR), virus induced antibodies by immunofluorescence assay (IFA) or by enzyme linked immunosorbant assay (ELISA) of nucleocapsid protein (NP). The spike glycoprotein of SARS-CoV is the major inducer of neutralizing antibodies. The receptor binding domain (RBD) in the S1 region of the spike glycoprotein contains multiple conformational epitopes that induces highly potent neutralizing antibodies. The genetically engineered attenuated form of the virus or viral vector vaccine encoding for the SARS-CoV spike glycoprotein has been shown to elicit protective immunity in vaccinated animals.</AbstractText>
<AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">NP is the preferred target for routine detection of SARS-CoV infection by ELISA which is an economical method compared to other methods. The RBD of the spike glycoprotein is both a functional domain for cell receptor binding and also a major neutralizing determinant of SARS-CoV. The progress in evaluating a therapeutic or vaccine would depend on the avail ability of clinically relevant animal model.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Suresh</LastName>
<ForeName>Mavanur R</ForeName>
<Initials>MR</Initials>
<AffiliationInfo><Affiliation>Faculty of Pharmacy and Pharmaceutical Sciences, University of Alberta, Edmonton, Alberta, Canada. msuresh@pharmacy.ualberta.ca</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Bhatnagar</LastName>
<ForeName>Pravin K</ForeName>
<Initials>PK</Initials>
</Author>
<Author ValidYN="Y"><LastName>Das</LastName>
<ForeName>Dipankar</ForeName>
<Initials>D</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<GrantList CompleteYN="Y"><Grant><GrantID>U01 AI061233</GrantID>
<Acronym>AI</Acronym>
<Agency>NIAID NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant><GrantID>U01 AI061233-02</GrantID>
<Acronym>AI</Acronym>
<Agency>NIAID NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant><GrantID>5U01AI061233-02</GrantID>
<Acronym>AI</Acronym>
<Agency>NIAID NIH HHS</Agency>
<Country>United States</Country>
</Grant>
</GrantList>
<PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic"><Year>2008</Year>
<Month>04</Month>
<Day>19</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo><Country>Canada</Country>
<MedlineTA>J Pharm Pharm Sci</MedlineTA>
<NlmUniqueID>9807281</NlmUniqueID>
<ISSNLinking>1482-1826</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList><Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D000914">Antibodies, Viral</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D000956">Antigens, Viral</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D000939">Epitopes</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D019590">Nucleocapsid Proteins</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D014759">Viral Envelope Proteins</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D014764">Viral Proteins</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D014765">Viral Vaccines</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList><MeshHeading><DescriptorName UI="D000281" MajorTopicYN="N">Administration, Intranasal</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000914" MajorTopicYN="N">Antibodies, Viral</DescriptorName>
<QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000956" MajorTopicYN="N">Antigens, Viral</DescriptorName>
<QualifierName UI="Q000008" MajorTopicYN="N">administration & dosage</QualifierName>
<QualifierName UI="Q000032" MajorTopicYN="N">analysis</QualifierName>
<QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D002170" MajorTopicYN="N" Type="Geographic">Canada</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D002522" MajorTopicYN="N">Chlorocebus aethiops</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D004797" MajorTopicYN="N">Enzyme-Linked Immunosorbent Assay</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000939" MajorTopicYN="N">Epitopes</DescriptorName>
<QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
<QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D009500" MajorTopicYN="N">Neutralization Tests</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D019590" MajorTopicYN="N">Nucleocapsid Proteins</DescriptorName>
<QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D020133" MajorTopicYN="N">Reverse Transcriptase Polymerase Chain Reaction</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D045473" MajorTopicYN="N">SARS Virus</DescriptorName>
<QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
<QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
<QualifierName UI="Q000302" MajorTopicYN="Y">isolation & purification</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D045169" MajorTopicYN="N">Severe Acute Respiratory Syndrome</DescriptorName>
<QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName>
<QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName>
<QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
<QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
<QualifierName UI="Q000517" MajorTopicYN="N">prevention & control</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D014709" MajorTopicYN="N">Vero Cells</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D014759" MajorTopicYN="N">Viral Envelope Proteins</DescriptorName>
<QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D014764" MajorTopicYN="N">Viral Proteins</DescriptorName>
<QualifierName UI="Q000008" MajorTopicYN="N">administration & dosage</QualifierName>
<QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D014765" MajorTopicYN="N">Viral Vaccines</DescriptorName>
<QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
<QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2009</Year>
<Month>2</Month>
<Day>11</Day>
<Hour>9</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed"><Year>2009</Year>
<Month>2</Month>
<Day>11</Day>
<Hour>9</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2009</Year>
<Month>4</Month>
<Day>29</Day>
<Hour>9</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>epublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">19203466</ArticleId>
<ArticleId IdType="pmc">PMC2678938</ArticleId>
<ArticleId IdType="mid">NIHMS102629</ArticleId>
<ArticleId IdType="doi">10.18433/j3j019</ArticleId>
</ArticleIdList>
<ReferenceList><Reference><Citation>Lancet. 2003 Apr 19;361(9366):1319-25</Citation>
<ArticleIdList><ArticleId IdType="pubmed">12711465</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>N Engl J Med. 2003 May 15;348(20):1995-2005</Citation>
<ArticleIdList><ArticleId IdType="pubmed">12671061</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>N Engl J Med. 2003 May 15;348(20):1967-76</Citation>
<ArticleIdList><ArticleId IdType="pubmed">12690091</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>N Engl J Med. 2003 May 15;348(20):1953-66</Citation>
<ArticleIdList><ArticleId IdType="pubmed">12690092</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Nature. 2003 May 15;423(6937):240</Citation>
<ArticleIdList><ArticleId IdType="pubmed">12748632</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Science. 2003 May 30;300(5624):1394-9</Citation>
<ArticleIdList><ArticleId IdType="pubmed">12730500</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Science. 2003 May 30;300(5624):1399-404</Citation>
<ArticleIdList><ArticleId IdType="pubmed">12730501</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Science. 2003 May 30;300(5624):1377-8</Citation>
<ArticleIdList><ArticleId IdType="pubmed">12775826</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Lancet. 2003 May 24;361(9371):1767-72</Citation>
<ArticleIdList><ArticleId IdType="pubmed">12781535</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Science. 2003 Jun 13;300(5626):1763-7</Citation>
<ArticleIdList><ArticleId IdType="pubmed">12746549</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Virol. 2003 Aug;77(16):8801-11</Citation>
<ArticleIdList><ArticleId IdType="pubmed">12885899</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Hong Kong Med J. 2003 Aug;9(4):309; author reply 310</Citation>
<ArticleIdList><ArticleId IdType="pubmed">12904626</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Biochem Biophys Res Commun. 2003 Oct 10;310(1):78-83</Citation>
<ArticleIdList><ArticleId IdType="pubmed">14511651</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Clin Microbiol. 2003 Oct;41(10):4521-4</Citation>
<ArticleIdList><ArticleId IdType="pubmed">14532176</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Science. 2003 Oct 10;302(5643):276-8</Citation>
<ArticleIdList><ArticleId IdType="pubmed">12958366</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Proc Natl Acad Sci U S A. 2003 Nov 11;100(23):13190-5</Citation>
<ArticleIdList><ArticleId IdType="pubmed">14585926</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Transfus Med. 2003 Oct;13(5):259-66</Citation>
<ArticleIdList><ArticleId IdType="pubmed">14617336</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Clin Chem. 2003 Dec;49(12):1989-96</Citation>
<ArticleIdList><ArticleId IdType="pubmed">14633869</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Clin Chem. 2003 Dec;49(12):2085-8</Citation>
<ArticleIdList><ArticleId IdType="pubmed">14633884</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Clin Chem. 2003 Dec;49(12):2108-9</Citation>
<ArticleIdList><ArticleId IdType="pubmed">14633896</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Biochem Biophys Res Commun. 2003 Dec 26;312(4):1159-64</Citation>
<ArticleIdList><ArticleId IdType="pubmed">14651994</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Biochem Biophys Res Commun. 2003 Dec 26;312(4):1290-6</Citation>
<ArticleIdList><ArticleId IdType="pubmed">14652014</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Nature. 2003 Nov 27;426(6965):450-4</Citation>
<ArticleIdList><ArticleId IdType="pubmed">14647384</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Clin Microbiol. 2003 Dec;41(12):5781-2</Citation>
<ArticleIdList><ArticleId IdType="pubmed">14662982</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Lancet. 2003 Dec 6;362(9399):1895-6</Citation>
<ArticleIdList><ArticleId IdType="pubmed">14667748</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Clin Infect Dis. 2004 Jan 15;38(2):293-6</Citation>
<ArticleIdList><ArticleId IdType="pubmed">14699465</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Biochem Biophys Res Commun. 2004 Jan 23;313(4):938-47</Citation>
<ArticleIdList><ArticleId IdType="pubmed">14706633</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Clin Chem. 2004 Jan;50(1):67-72</Citation>
<ArticleIdList><ArticleId IdType="pubmed">14709637</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Biol Chem. 2004 Jan 30;279(5):3197-201</Citation>
<ArticleIdList><ArticleId IdType="pubmed">14670965</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Biochem Biophys Res Commun. 2004 Feb 20;314(4):931-6</Citation>
<ArticleIdList><ArticleId IdType="pubmed">14751221</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Biochem Biophys Res Commun. 2004 Mar 5;315(2):439-44</Citation>
<ArticleIdList><ArticleId IdType="pubmed">14766227</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Clin Microbiol. 2004 Mar;42(3):987-91</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15004042</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Clin Diagn Lab Immunol. 2004 Mar;11(2):417-22</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15013997</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Virol. 2004 Apr;78(7):3572-7</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15016880</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Emerg Infect Dis. 2004 Feb;10(2):294-9</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15030700</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Emerg Infect Dis. 2004 Feb;10(2):304-10</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15030702</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Virol. 2004 Apr;78(8):4330-41</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15047846</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Nature. 2004 Apr 1;428(6982):561-4</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15024391</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Clin Microbiol. 2004 Apr;42(4):1471-6</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15070991</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Immunol Lett. 2004 Sep;95(2):139-43</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15388253</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Biochem Biophys Res Commun. 2004 Nov 12;324(2):773-81</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15474494</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Virol Methods. 2004 Dec 1;122(1):29-36</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15488617</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Virol Methods. 2004 Dec 1;122(1):105-11</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15488627</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Virol. 1987 Aug;61(8):2607-13</Citation>
<ArticleIdList><ArticleId IdType="pubmed">3599183</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Virology. 1990 Nov;179(1):463-8</Citation>
<ArticleIdList><ArticleId IdType="pubmed">2171216</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Virology. 1991 Mar;181(1):327-35</Citation>
<ArticleIdList><ArticleId IdType="pubmed">1847259</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Curr Opin Mol Ther. 2005 Apr;7(2):151-6</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15844623</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Virol Methods. 2005 Jul;127(1):46-53</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15893565</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Proc Natl Acad Sci U S A. 2005 Jun 21;102(25):9062-7</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15956182</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Sheng Wu Gong Cheng Xue Bao. 2005 Mar;21(2):211-5</Citation>
<ArticleIdList><ArticleId IdType="pubmed">16013477</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Emerg Infect Dis. 2005 Jul;11(7):1016-20</Citation>
<ArticleIdList><ArticleId IdType="pubmed">16022774</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Clin Microbiol. 2005 Aug;43(8):3718-26</Citation>
<ArticleIdList><ArticleId IdType="pubmed">16081901</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>DNA Cell Biol. 2005 Aug;24(8):503-9</Citation>
<ArticleIdList><ArticleId IdType="pubmed">16101348</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Virol. 2005 Sep;79(18):11638-46</Citation>
<ArticleIdList><ArticleId IdType="pubmed">16140741</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Mol Biol. 2005 Nov 11;353(5):1137-51</Citation>
<ArticleIdList><ArticleId IdType="pubmed">16219322</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Biomed Sci. 2005 Oct;12(5):711-27</Citation>
<ArticleIdList><ArticleId IdType="pubmed">16132115</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Vaccine. 2006 Feb 13;24(7):863-71</Citation>
<ArticleIdList><ArticleId IdType="pubmed">16191455</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Gen Virol. 2006 Mar;87(Pt 3):641-50</Citation>
<ArticleIdList><ArticleId IdType="pubmed">16476986</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Virol Methods. 2006 Nov;137(2):343-6</Citation>
<ArticleIdList><ArticleId IdType="pubmed">16904198</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Virology. 2007 Mar 15;359(2):264-74</Citation>
<ArticleIdList><ArticleId IdType="pubmed">17055022</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Emerg Infect Dis. 2006 Dec;12(12):1834-40</Citation>
<ArticleIdList><ArticleId IdType="pubmed">17326933</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Vaccine. 2007 Apr 12;25(15):2832-8</Citation>
<ArticleIdList><ArticleId IdType="pubmed">17092615</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Vaccine. 2007 Sep 28;25(39-40):6981-91</Citation>
<ArticleIdList><ArticleId IdType="pubmed">17709158</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Immunol. 2008 Jan 15;180(2):948-56</Citation>
<ArticleIdList><ArticleId IdType="pubmed">18178835</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Immunol Methods. 2008 Feb 29;331(1-2):1-12</Citation>
<ArticleIdList><ArticleId IdType="pubmed">18191140</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Chromatogr B Analyt Technol Biomed Life Sci. 2008 Mar 1;863(2):235-41</Citation>
<ArticleIdList><ArticleId IdType="pubmed">18258500</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Vaccine. 2008 Mar 20;26(13):1644-51</Citation>
<ArticleIdList><ArticleId IdType="pubmed">18289745</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Clin Microbiol. 2000 Apr;38(4):1430-3</Citation>
<ArticleIdList><ArticleId IdType="pubmed">10747120</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Virology. 2001 Jan 20;279(2):371-4</Citation>
<ArticleIdList><ArticleId IdType="pubmed">11162792</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Acta Virol. 2001 Feb;45(1):31-8</Citation>
<ArticleIdList><ArticleId IdType="pubmed">11394575</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Clin Microbiol. 2001 Sep;39(9):3110-4</Citation>
<ArticleIdList><ArticleId IdType="pubmed">11526137</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Clin Microbiol. 2001 Nov;39(11):3830-7</Citation>
<ArticleIdList><ArticleId IdType="pubmed">11682494</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Virol. 2002 May;76(10):4987-99</Citation>
<ArticleIdList><ArticleId IdType="pubmed">11967315</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Clin Microbiol. 2002 Jun;40(6):2041-5</Citation>
<ArticleIdList><ArticleId IdType="pubmed">12037061</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Viral Immunol. 2008 Mar;21(1):27-37</Citation>
<ArticleIdList><ArticleId IdType="pubmed">18355120</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Virol Methods. 2008 Sep;152(1-2):77-84</Citation>
<ArticleIdList><ArticleId IdType="pubmed">18620761</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Clin Microbiol. 2004 Apr;42(4):1570-6</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15071006</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Virol. 2004 May;78(9):4552-60</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15078936</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Virol. 2004 May;78(9):4638-45</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15078946</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Immunol Lett. 2004 Apr 15;92(3):237-43</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15081618</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Biochem Biophys Res Commun. 2004 May 14;317(4):1030-6</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15094372</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Emerg Infect Dis. 2004 Mar;10(3):530-2</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15109430</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Proc Natl Acad Sci U S A. 2004 Apr 27;101(17):6641-6</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15096611</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Clin Microbiol. 2004 May;42(5):2306-9</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15131220</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Clin Virol. 2004 Jul;30(3):214-7</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15135737</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Clin Virol. 2004 Aug;30(4):309-12</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15163419</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Clin Microbiol. 2004 Jun;42(6):2629-35</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15184444</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Virol. 2004 Jul;78(13):7217-26</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15194798</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Emerg Infect Dis. 2004 May;10(5):825-31</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15200815</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Infect Dis. 2004 Jul 15;190(2):379-86</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15216476</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Proc Natl Acad Sci U S A. 2004 Jun 29;101(26):9804-9</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15210961</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Virol Methods. 2004 Sep 1;120(1):33-40</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15234807</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Can J Vet Res. 2002 Oct;66(4):278-81</Citation>
<ArticleIdList><ArticleId IdType="pubmed">12418784</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Clin Microbiol. 2002 Dec;40(12):4603-6</Citation>
<ArticleIdList><ArticleId IdType="pubmed">12454159</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Avian Dis. 2002 Oct-Dec;46(4):831-8</Citation>
<ArticleIdList><ArticleId IdType="pubmed">12495043</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Clin Microbiol. 2003 Jan;41(1):135-43</Citation>
<ArticleIdList><ArticleId IdType="pubmed">12517838</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Clin Microbiol. 2003 Feb;41(2):845-50</Citation>
<ArticleIdList><ArticleId IdType="pubmed">12574298</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Clin Microbiol. 2003 Mar;41(3):1016-22</Citation>
<ArticleIdList><ArticleId IdType="pubmed">12624024</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Virol Methods. 2003 May;109(2):139-42</Citation>
<ArticleIdList><ArticleId IdType="pubmed">12711056</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Clin Diagn Lab Immunol. 2004 Jul;11(4):665-8</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15242938</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Immunol. 2004 Sep 15;173(6):4050-7</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15356154</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Clin Microbiol. 1992 Sep;30(9):2338-45</Citation>
<ArticleIdList><ArticleId IdType="pubmed">1400999</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Gen Virol. 1993 Jul;74 ( Pt 7):1287-94</Citation>
<ArticleIdList><ArticleId IdType="pubmed">8393072</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Vet Immunol Immunopathol. 1995 Sep;48(1-2):35-54</Citation>
<ArticleIdList><ArticleId IdType="pubmed">8533315</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Virol. 1998 Aug;72(8):6838-50</Citation>
<ArticleIdList><ArticleId IdType="pubmed">9658133</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Lancet Infect Dis. 2004 Nov;4(11):663-71</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15522678</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Clin Microbiol. 2004 Nov;42(11):5309-14</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15528730</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Biochem Biophys Res Commun. 2004 Dec 10;325(2):445-52</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15530413</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Nat Med. 2004 Dec;10(12 Suppl):S88-97</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15577937</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Virol. 2005 Jan;79(2):884-95</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15613317</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Clin Diagn Lab Immunol. 2005 Jan;12(1):135-40</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15642998</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Virol. 2005 Feb;79(3):1906-10</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15650214</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Immunol Methods. 2005 Jan;296(1-2):37-44</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15680149</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Respir Res. 2005;6:8</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15661082</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Biochem Biophys Res Commun. 2005 Mar 25;328(4):979-86</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15707974</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Virol. 2005 Mar;79(6):3289-96</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15731223</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Virology. 2005 Mar 30;334(1):74-82</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15749124</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Clin Virol. 2005 May;33(1):12-8</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15797360</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Immunol. 2005 Apr 15;174(8):4908-15</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15814718</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
</PubmedData>
</pubmed>
<affiliations><list><country><li>Canada</li>
</country>
</list>
<tree><noCountry><name sortKey="Bhatnagar, Pravin K" sort="Bhatnagar, Pravin K" uniqKey="Bhatnagar P" first="Pravin K" last="Bhatnagar">Pravin K. Bhatnagar</name>
<name sortKey="Das, Dipankar" sort="Das, Dipankar" uniqKey="Das D" first="Dipankar" last="Das">Dipankar Das</name>
</noCountry>
<country name="Canada"><noRegion><name sortKey="Suresh, Mavanur R" sort="Suresh, Mavanur R" uniqKey="Suresh M" first="Mavanur R" last="Suresh">Mavanur R. Suresh</name>
</noRegion>
</country>
</tree>
</affiliations>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/SrasV1/Data/PubMed/Checkpoint
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001A85 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd -nk 001A85 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Sante |area= SrasV1 |flux= PubMed |étape= Checkpoint |type= RBID |clé= pubmed:19203466 |texte= Molecular targets for diagnostics and therapeutics of severe acute respiratory syndrome (SARS-CoV). }}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/RBID.i -Sk "pubmed:19203466" \ | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd \ | NlmPubMed2Wicri -a SrasV1
![]() | This area was generated with Dilib version V0.6.33. | ![]() |